We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HVO market cap is 140.16M. The company's latest EPS is EUR 0.0237 and P/E is 8.65.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 3.84M | 20.6M | 36.86M | 48.48M | 56.04M |
Operating Income | -5.72M | -10.61M | 492k | 5.98M | 10.09M |
Net Income | -6.54M | -10.79M | -74k | -776k | 16.12M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 10.63M | 48.55M | 42.27M | 51.38M | 83.23M |
Total Liabilities | 7.28M | 26.25M | 21.59M | 31.16M | 48.9M |
Total Equity | 3.35M | 22.3M | 20.68M | 20.22M | 34.33M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -3.25M | 4.17M | -1.56M | 15.98M | 17.24M |
Investing | 487k | 1.18M | -739k | -1.36M | -5.18M |
Financing | 3.82M | 13.04M | -1.2M | -1.83M | -3.52M |
Market Cap | 140.16M |
Price to Earnings Ratio | 8.65 |
Price to Sales Ratio | 2.49 |
Price to Cash Ratio | 3.78 |
Price to Book Ratio | 4.06 |
Dividend Yield | 0.97% |
Shares Outstanding | 680.37M |
Average Volume (1 week) | 611.91k |
Average Volume (1 Month) | 1.61M |
52 Week Change | -16.77% |
52 Week High | 31.00 |
52 Week Low | 18.10 |
Spread (Intraday) | 1 (4.76%) |
Company Name | Hvivo Plc |
Address |
floor 24 london E14 5NR |
Website | https://www.hvivo.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions